Literature DB >> 15206779

The enol tautomer of indole-3-pyruvic acid as a biological switch in stress responses.

Barbara Bartolini1, Cristina Corniello, Antonio Sella, Francesca Somma, Vincenzo Politi.   

Abstract

Indole-3-pyruvic acid (IPA) undergoes in solutions to the keto-enol tautomerism, which appears responsible of its pharmacological effects, as only the enol tautomer is an easy target for oxygen free-radicals and can be transformed directly to kynurenic acid (KYNA). Contrary to expectations, the IPA enol tautomer is rather stable in mammalian tissues, due to the presence of specific tautomerases, favouring the formation of KYNA in the presence of free-radicals. Because of the synergistic effects between glucocorticoids, free-radicals and excitatory aminoacids in chronic stress, the enol tautomer of IPA and KYNA are proposed as physiological metabolites produced in order to shut-off the chronic stress cycle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15206779     DOI: 10.1007/978-1-4615-0135-0_69

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Tales from the war on error: the art and science of curating QSAR data.

Authors:  Marvin Waldman; Robert Fraczkiewicz; Robert D Clark
Journal:  J Comput Aided Mol Des       Date:  2015-08-20       Impact factor: 3.686

2.  Pharmacophoric features of drugs with guanylurea moiety: an electronic structure analysis.

Authors:  Yoganjaneyulu Kasetti; Prasad V Bharatam
Journal:  J Mol Model       Date:  2013-01-17       Impact factor: 1.810

Review 3.  An Emerging Cross-Species Marker for Organismal Health: Tryptophan-Kynurenine Pathway.

Authors:  Laiba Jamshed; Amrita Debnath; Shanza Jamshed; Jade V Wish; Jason C Raine; Gregg T Tomy; Philippe J Thomas; Alison C Holloway
Journal:  Int J Mol Sci       Date:  2022-06-04       Impact factor: 6.208

Review 4.  Relevance of Alternative Routes of Kynurenic Acid Production in the Brain.

Authors:  L A Ramos-Chávez; R Lugo Huitrón; D González Esquivel; B Pineda; C Ríos; D Silva-Adaya; L Sánchez-Chapul; G Roldán-Roldán; V Pérez de la Cruz
Journal:  Oxid Med Cell Longev       Date:  2018-05-24       Impact factor: 6.543

Review 5.  Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism.

Authors:  Masaru Tanaka; Zsuzsanna Bohár; László Vécsei
Journal:  Molecules       Date:  2020-01-28       Impact factor: 4.411

Review 6.  Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?

Authors:  Aleksandra Ostapiuk; Ewa M Urbanska
Journal:  CNS Neurosci Ther       Date:  2021-12-03       Impact factor: 5.243

Review 7.  Neuroprotection by radical avoidance: search for suitable agents.

Authors:  Rüdiger Hardeland
Journal:  Molecules       Date:  2009-12-07       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.